You might be interested in…Therapeutics Update (Part 1)
Dr Ray O’Connor takes a look at the latest clinical papers on therapeutics, including Dual Antiplatelet Therapy (DAPT)…
New findings do not support the use of edoxaban in AF patients after intracranial hemorrhage
Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation…
Stroke transfer delays reduce access to life-saving thrombectomy
Gaps in the nation’s stroke transfer system are drastically reducing survivors’ chances of receiving critical treatment and increasing…